These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7208581)

  • 1. [The dynamics of the drug release from tablets. Part 7: Comparison of three liberation models on Cholestil tablets (author's transl)].
    Pasich J; Niedworok E; Zajaç M
    Pharmazie; 1980 Dec; 35(12):778. PubMed ID: 7208581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The dynamics of the drug release from tablets. Part 6: Liberation of glaucine from Tussiglauzin Dragées (author's transl)].
    Pasich J; Niedworok E; Warzecha U
    Pharmazie; 1980 Dec; 35(12):777. PubMed ID: 7208580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The dynamics of the drug release from dragées. Part 3: Indometnacin (author's transl)].
    Wojdak H; Pasich J
    Pharmazie; 1980 Aug; 35(8):480-1. PubMed ID: 7433498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [On the polymorphism of Barbiturates in powers and tablets. Part 5: The dissolution of recrystallized barbital substances and their release from tablet (author's transl)].
    Hollenbach K; Pintye-Hódi K; Kedvessy G
    Pharmazie; 1980 Feb; 35(2):95-8. PubMed ID: 7384189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A study of release from tablets. A comparison of four methods (author's transl)].
    Fu YK; Xu AX; Bao JX; Li DL; Zhang XF; Xing CY
    Yao Xue Xue Bao; 1980 Jul; 15(7):422-8. PubMed ID: 7424529
    [No Abstract]   [Full Text] [Related]  

  • 6. [The dynamics of the drug release from ointment bases. Part 5: The effects of tensides on the liberation of atropine from eye ointments (author's transl)].
    Pasich J; Bether W; Malaga M
    Pharmazie; 1981 Apr; 36(4):267-9. PubMed ID: 7255527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discrepancy among dissolution rates of commercial tablets as a function of dissolution method. part 6: rifampicin.
    Ammar HO; Khalil RM
    Pharmazie; 1996 Mar; 51(3):165-8. PubMed ID: 8900866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative in vitro studies of allopurinol in commercial preparations].
    Georgarakis M; Iconomout N
    Pharmazie; 1984 Apr; 39(4):248-50. PubMed ID: 6739528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discrepancy among dissolution rates of commercial tablets as a function of dissolution method. Part 5: In vitro/in vivo correlation for chlorpromazine hydrochloride tablets.
    Ammar HO; Khalil RM; Omar SM
    Pharmazie; 1993 Dec; 48(12):932-5. PubMed ID: 8115438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug release in vitro from digoxin formulations with high bioavailability (author's transl)].
    Asmussen B; Heinz N
    Arzneimittelforschung; 1980; 30(12):2168-72. PubMed ID: 7194080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on dissolution in vitro of Zhike Pingchuan sustained-release tablets].
    Li X; Feng Z; Huo W; Li Y; Wang B; Zhu S
    Zhongguo Zhong Yao Za Zhi; 2009 May; 34(10):1216-9. PubMed ID: 19673379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modelling drug dissolution from controlled release products using genetic programming.
    Do DQ; Rowe RC; York P
    Int J Pharm; 2008 Mar; 351(1-2):194-200. PubMed ID: 18053658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
    Cao QR; Choi YW; Cui JH; Lee BJ
    J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro studies of drug liberation from suppositories with the rotating flask method].
    Koch HP; Klissenbauer C; Ritzinger A; Wallentin A
    Pharmazie; 1987 Mar; 42(3):169-72. PubMed ID: 3602072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thermoplastic granulation as an alternative method for the preparation of hydrophilic-lipophilic oral matriix tablets].
    Dvorácková K; Rabisková M; Masteiková R; Vocilková L
    Ceska Slov Farm; 2007 Jun; 56(3):129-34. PubMed ID: 17867525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro bioequivalence study of nine brands of artesunate tablets marketed in Nigeria.
    Esimone CO; Okoye FB; Onah BU; Nworu CS; Omeje EO
    J Vector Borne Dis; 2008 Mar; 45(1):60-5. PubMed ID: 18399319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A method for comparison of the dissolution rates in sustained release tablets (author's transl)].
    Gimet R; Milhaud JC; Rabiant J
    J Pharm Belg; 1976; 31(1):89-100. PubMed ID: 1255407
    [No Abstract]   [Full Text] [Related]  

  • 18. Dissolution properties of different designed and formulated salbutamol tablet dosage forms.
    Ozkan Y; Savaşer A; Ozalp Y; Işimer A
    Acta Pol Pharm; 2000; 57(4):271-6. PubMed ID: 11126615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applicability of (SBE)7m-beta-CD in controlled-porosity osmotic pump tablets (OPTs).
    Okimoto K; Tokunaga Y; Ibuki R; Irie T; Uekama K; Rajewski RA; Stella VJ
    Int J Pharm; 2004 Nov; 286(1-2):81-8. PubMed ID: 15501004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Electron-microscopic studies on the texture of sulphathiazole and sulphathiazole tablets (author's transl)].
    Kedvessy G; Selmeczi B; Pintye-Hódi K; Kala H; Moldenhauer H; Giese R
    Pharmazie; 1982 Feb; 37(2):132-4. PubMed ID: 7071119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.